Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joel Mawdsley

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
BMJ (Clinical Research Ed.)|November 27, 2004
Colonoscopy completion rates: technologies have evolvedPeter Irving, Joel Mawdsley, Richard Makins
British Journal of Hospital Medicine (London, England : 2005)|March 29, 2023
Management of orofacial granulomatosisSandeep Joshi, Joel Mawdsley, Esther Hullah, et al.
ILIVER|July 10, 2025
Setting up an integrated service for PSC-IBD patients: A quality improvement projectSreelakshmi Kotha, Ioannis Koumoutsos, Ben Warner, et al.
Gastrointestinal Endoscopy|April 29, 2008
High-risk features confer an increased risk of significant GI pathology in patients aged less than 50 years with dyspepsiaNick Powell, Joel Mawdsley, Jonathan Hoare, et al.
Inflammatory Bowel Diseases|June 23, 2020
Tofacitinib in Acute Severe Ulcerative Colitis-A Real-World Tertiary Center ExperienceSailish Honap, Polychronis Pavlidis, Shuvra Ray, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|January 24, 2022
Depression, anxiety, and stress among inflammatory bowel disease patients during COVID-19: A UK cohort studyRaphael P Luber, Alexa Duff, Polychronis Pavlidis, et al.
Frontline Gastroenterology|July 6, 2023
How achievable are STRIDE-II treatment targets in real-world practice and do they predict long-term treatment outcomes?Susanna Meade, Emma Routledge, Esha Sharma, et al.
Journal of Immunological Methods|October 10, 2006
New flow cytometric technique for the evaluation of circulating endothelial progenitor cell levels in various disease groupsAnna Dulic-Sills, Mark J Blunden, Joel Mawdsley, et al.
Alimentary Pharmacology & Therapeutics|June 8, 2020
Therapeutic thresholds for golimumab serum concentrations during induction and maintenance therapy in ulcerative colitis: results from the GO-LEVEL studyMark A Samaan, Georgina Cunningham, Aravind Gokul Tamilarasan, et al.
Frontline Gastroenterology|May 19, 2020
Effectiveness of vedolizumab dose intensification to achieve inflammatory bowel disease control in cases of suboptimal responseMark A Samaan, Siddharth Birdi, Maria Sierra Morales, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
BMJ (Clinical Research Ed.)|November 27, 2004
Colonoscopy completion rates: technologies have evolvedPeter Irving, Joel Mawdsley, Richard Makins
British Journal of Hospital Medicine (London, England : 2005)|March 29, 2023
Management of orofacial granulomatosisSandeep Joshi, Joel Mawdsley, Esther Hullah, et al.
ILIVER|July 10, 2025
Setting up an integrated service for PSC-IBD patients: A quality improvement projectSreelakshmi Kotha, Ioannis Koumoutsos, Ben Warner, et al.
Gastrointestinal Endoscopy|April 29, 2008
High-risk features confer an increased risk of significant GI pathology in patients aged less than 50 years with dyspepsiaNick Powell, Joel Mawdsley, Jonathan Hoare, et al.
Inflammatory Bowel Diseases|June 23, 2020
Tofacitinib in Acute Severe Ulcerative Colitis-A Real-World Tertiary Center ExperienceSailish Honap, Polychronis Pavlidis, Shuvra Ray, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|January 24, 2022
Depression, anxiety, and stress among inflammatory bowel disease patients during COVID-19: A UK cohort studyRaphael P Luber, Alexa Duff, Polychronis Pavlidis, et al.
Frontline Gastroenterology|July 6, 2023
How achievable are STRIDE-II treatment targets in real-world practice and do they predict long-term treatment outcomes?Susanna Meade, Emma Routledge, Esha Sharma, et al.
Journal of Immunological Methods|October 10, 2006
New flow cytometric technique for the evaluation of circulating endothelial progenitor cell levels in various disease groupsAnna Dulic-Sills, Mark J Blunden, Joel Mawdsley, et al.
Alimentary Pharmacology & Therapeutics|June 8, 2020
Therapeutic thresholds for golimumab serum concentrations during induction and maintenance therapy in ulcerative colitis: results from the GO-LEVEL studyMark A Samaan, Georgina Cunningham, Aravind Gokul Tamilarasan, et al.
Frontline Gastroenterology|May 19, 2020
Effectiveness of vedolizumab dose intensification to achieve inflammatory bowel disease control in cases of suboptimal responseMark A Samaan, Siddharth Birdi, Maria Sierra Morales, et al.
Pageof 2